Your browser doesn't support javascript.
loading
The diagnostic value of modified systemic inflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent isolated limb perfusion.
Morkavuk, Sevket Baris; Çulcu, Serdar; Esen, Ebru; Ünal, Ali Ekrem.
Afiliación
  • Morkavuk SB; Department of Surgical Oncology, Ankara City Hospital, Ankara, Turkey. drsbmor@yahoo.com.
  • Çulcu S; Department of Surgical Oncology, Dr. Abdurrahman Yurtaslan Research and Training Hospital, Ankara, Turkey.
  • Esen E; Department of Surgical Oncology, Ankara Gülhane Research and Training Hospital, Ankara, Turkey.
  • Ünal AE; Department of Surgical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
World J Surg Oncol ; 19(1): 327, 2021 Nov 16.
Article en En | MEDLINE | ID: mdl-34781987
ABSTRACT

BACKGROUND:

In-transit metastasis is considered a locoregional disease in cutaneous melanoma (CM) patients. Isolated limb perfusion (ILP) is among the treatment options in selected cases. The aim of this study was to determine the success of pre- and post-perfusion mSIS values in predicting the potential complications and the prognosis of the disease by investigating the early and long-term results of mSIS values calculated before and after ILP in CM cases with in-transit metastases. MATERIALS AND

METHODS:

Patients who underwent ILP within the period from 2014 to 2020 in our department were retrospectively scanned. A total of 20 patients were found to undergo ILP. The scores obtained from modified inflammation score (mSIS) were formulated according to albumin (Alb) and lymphocyte to monocyte ratio (LMR) scores.

RESULTS:

The mean follow-up time was 20.47 months. Complications requiring surgical intervention developed in three patients. According to the Wieberdink local toxicity classification, the majority (70%) of the patients were found to be grade II. Based on pre-perfusion mSIS values, 8 patients were classified as mSIS 0 while six patients were classified as mSIS 1 and 2. Based on post-perfusion mSIS values, 14 patients and one patient were classified as mSIS 2 (70%) and mSIS 0, respectively. Accordingly, univariate analysis showed that mSIS 1 and mSIS 2 were negative prognostic factors for mean survival in the pre-perfusion period (HR 0.162, 95% CI 0.036-0.729; p = 0.018 and HR 0.223, 95% CI 0.049-1.019; p = 0.053) whereas albumin (Alb) and lymphocyte to monocyte ratio (LMR) were not independent prognostic factors for mean survival.

CONCLUSION:

The mSIS values calculated in the pre-perfusion period can give an opinion about the OS of the patients whereas post-perfusion mSIS values may predict potential surgical complications and local toxicities.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: World J Surg Oncol Año: 2021 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: World J Surg Oncol Año: 2021 Tipo del documento: Article País de afiliación: Turquía
...